Johan W. de Fijter

A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1

Teun van Gelder, Luuk B. Hilbrands, Yves Vanrenterghem et al. · Transplantation · 1999 · 540 citations

Medicine, Pharmacokinetics, Pharmacology +17

Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

Bengt Fellström, Jonathan Barratt, H. Terence Cook et al. · The Lancet · 2017 · 402 citations · Full text

Medicine, Nephrology, Pharmacotherapy +10

Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

Marlies E. J. Reinders, Johan W. de Fijter, Helene Roelofs et al. · Stem Cells Translational Medicine · 2013 · 363 citations · Full text

Medicine, Clinical Sciences, Nephrology +17

Delayed graft function influences renal function, but not survival

Henk Boom, Marko J.K. Mallat, Johan W. de Fijter et al. · Kidney International · 2000 · 317 citations · Full text

Medicine, Nephrology, Surgery +14

Comparing Mycophenolate Mofetil Regimens for de Novo Renal Transplant Recipients: The Fixed-Dose Concentration-Controlled Trial

Teun van Gelder, Hélio Tedesco‐Silva, Johan W. de Fijter et al. · Transplantation · 2008 · 280 citations

Medicine, Pharmacology, Pharmacotherapy +16